A study in the Journal of the American Academy of Orthopaedic Surgeons investigates
ROSEMONT, Ill. (September 9, 2016)—Knee pain is common among Americans age 40 and up. Nearly 1 in 17 people visit doctors’ offices each year for knee pain or injuries from osteoarthritis—a progressive “wear and tear” disease of the joints. Those odds increase as the U.S. population continues to age and becomes even more overweight. While a magnetic resonance imaging (MRI) is one tool that can help doctors diagnose torn knee ligaments and cartilage and other problems, plain X-rays are the best first line screening tools for knee pain.
According to a study in the September issue of the Journal of American Academy of Orthopaedic Surgeons (JAAOS), a simple X-ray is frequently the best diagnostic tool, reducing both time and cost.
Whether a patient will need surgery for knee problems depends on how much arthritis he or she has. “If an X-ray shows that a person has significant arthritis, the MRI findings—like a meniscus tear—are less important because the amount of arthritis often dictates the treatment. Therefore, patients should always get a standing X-ray before getting an MRI to screen for knee pain in patients older than 40,” says Muyibat Adelani, MD, an orthopaedic surgeon with Washington University’s Department of Orthopedics and lead author of this study.
The study looked at 600 MRIs of knees from patients age 40 and up and found that:
- The most common diagnoses are osteoarthritis (39 percent), and meniscal tears (29 percent)—the tearing of the wedge-shaped pieces of cartilage in the knee joint;
- Nearly 1 of 4 MRIs was taken prior to the patient’s first having obtained a weight-bearing X-ray; and,
- Only half of those MRIs obtained prior to meeting with an orthopaedic surgeon actually contributed to a patient’s diagnosis and treatment for osteoarthritis.
More information about the AAOS
Follow the AAOS on Facebook, Twitter, and #JAAOS
Disclosures: From the Department of Orthopedics, Washington University, St. Louis, Mo. (Dr. Adelani, Dr. Brophy, Dr. Halstead, Dr. Smith, and Dr. Wright) and St. Louis Center for Cartilage Restoration and Repair, St. Louis (Dr. Mall).
Dr. Mall or an immediate family member is a member of a speakers’ bureau or has made paid presentations on behalf of Arthrex. Dr. Brophy or an immediate family member has stock or stock options held in Ostesys, and serves as a board member, owner, officer, or committee member of The American Orthopaedic Association, the American Orthopaedic Society for Sports Medicine, and the Orthopaedic Research Society. Dr. Halstead or an immediate family member serves as a board member, owner, officer, or committee member of the American Medical Society for Sports Medicine. Dr. Smith or an immediate family member is a member of a speakers’ bureau or has made paid presentations on behalf of Arthrex. Dr. Wright or an immediate family member has received research or institutional support from the National Institutes of Health (NIAMS and NICHD) and serves as a board member, owner, officer, or committee member of the American Board of Orthopaedic Surgery, The American Orthopaedic Association, and the American Orthopaedic Society for Sports Medicine. Neither Dr. Adelani nor any immediate family member has received anything of value from or has stock or stock options held in a commercial company or institution related directly or indirectly to the subject of this article.